TENX - Tenax Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Tenax Therapeutics, Inc.

ONE Copley Parkway
Suite 490
Morrisville, NC 27560
United States
919-855-2100
http://www.tenaxthera.com

SectorHealthcare
IndustryBiotechnology
Full Time Employees9

Key Executives

NameTitlePayExercisedYear Born
Mr. Anthony A. DiTonnoCEO & Director389.21kN/A1948
Mr. Michael B. JebsenPres & CFO680.81kN/A1971
Ms. Nancy J. M. HecoxExec. VP of Legal Affairs, Gen. Counsel & Corp. Sec.N/AN/AN/A
Maria Isabel TomargoAssistant VP of Marketing & SalesN/AN/AN/A
Mr. Robert F. DiegelmannHead of New Wound Care DivisionN/AN/AN/A
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Tenax Therapeutics, Inc., a specialty pharmaceutical company, focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases in the United States and Canada. The company focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing low cardiac output syndrome. It is also involved in initiating a Phase 2 clinical trial of levosimendan for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.

Corporate Governance

Tenax Therapeutics, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.